Literature DB >> 32498338

Comparative Analysis of Age- and Gender-Associated Microbiome in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Lindsay M Wong1,2, Neil Shende1,2, Wei Tse Li1,2, Grant Castaneda1,2, Lauren Apostol1,2, Eric Y Chang3,4, Weg M Ongkeko1,2.   

Abstract

The intra-tumor microbiota has been increasingly implicated in cancer pathogenesis. In this study, we aimed to examine the microbiome in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) and determine its compositional differences with relation to age and gender. After grouping 497 LUAD and 433 LUSC patients by age and gender and removing potential contaminants, we identified differentially abundant microbes in each patient cohort vs. adjacent normal samples. We then correlated dysregulated microbes with patient survival rates, immune infiltration, immune and cancer pathways, and genomic alterations. We found that most age and gender cohorts in both LUAD and LUSC contained unique, significantly dysregulated microbes. For example, LUAD-associated Escherichia coli str. K-12 substr. W3110 was dysregulated in older female and male patients and correlated with both patient survival and genomic alterations. For LUSC, the most prominent bacterial species that we identified was Pseudomonas putida str. KT2440, which was uniquely associated with young LUSC male patients and immune infiltration. In conclusion, we found differentially abundant microbes implicated with age and gender that are also associated with genomic alterations and immune dysregulations. Further investigation should be conducted to determine the relationship between gender and age-associated microbes and the pathogenesis of lung cancer.

Entities:  

Keywords:  TCGA; age; gender; lung adenocarcinoma; lung squamous cell carcinoma; microbiome

Year:  2020        PMID: 32498338     DOI: 10.3390/cancers12061447

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  2 in total

1.  Distinct bronchial microbiome precedes clinical diagnosis of lung cancer.

Authors:  Janice M Leung; Wan L Lam; Erin A Marshall; Fernando S L Filho; Don D Sin; Stephen Lam
Journal:  Mol Cancer       Date:  2022-03-07       Impact factor: 27.401

2.  Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Nengchao Wang; Yue Xu; Linzhi Jin; Xiaomin Wang; Shouxin Wu; Yu Wang; Jiangman Zhao; Fuyou Zhou; Hong Ge
Journal:  Dis Markers       Date:  2022-08-23       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.